The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Pulmonary aspergillosis: a clinical review
Open accessAbstract
Aspergillus is a mould which may lead to a variety of infectious, allergic diseases depending on the host's immune status or pulmonary structure. Invasive pulmonary aspergillosis occurs primarily in patients with severe immunodeficiency. The significance of this infection has dramatically increased with growing numbers of patients with impaired immune state associated with the management of malignancy, organ transplantation, autoimmune and inflammatory conditions; critically ill patients and those with chronic obstructive pulmonary disease appear to be at an increased risk. The introduction of new noninvasive tests, combined with more effective and better-tolerated antifungal agents, has resulted in lower mortality rates associated with this infection. Chronic necrotising aspergillosis is a locally invasive disease described in patients with chronic lung disease or mild immunodeficiency. Aspergilloma is usually found in patients with previously formed cavities in the lung, whereas allergic bronchopulmonary aspergillosis, a hypersensitivity reaction to Aspergillus antigens, is generally seen in patients with atopy, asthma or cystic fibrosis. This review provides an update on the evolving epidemiology and risk factors of the major manifestations of Aspergillus lung disease and the clinical manifestations that should prompt the clinician to consider these conditions. Current approaches for the diagnosis and management of these syndromes are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
Serologic Monitoring of Disease and Treatment in a Patient with Pulmonary Aspergilloma
Tomee, J. F. C., van der Werf, T. S., Latgé, J., Koëter, G. H., Dubois, A. E. J., & Kauffman, H. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812553 · Cited by 50
Tj, W., & Ah, G. (2001) · PubMed · Cited by 50
Klont, R. R., Mennink‐Kersten, M. A. S. H., Ruegebrink, D., Rijs, A. J. M. M., Blijlevens, N. M. A., Donnelly, J. P., & Verweij, P. E. (2006) · Clinical Infectious Diseases · doi:10.1086/505603 · Cited by 49
Immunologic Aspects of Lung Diseases and Cystic Fibrosis
Greenberger, P. A. (1997) · JAMA · doi:10.1001/jama.1997.03550220130017 · Cited by 48
Lee, K. S., Kim, H. T., Kim, Y. H., et al. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.161.4.8372746 · Cited by 48
Knutsen, A. P., & Slavin, R. G. (1989) · PubMed · Cited by 46
Antifungal prophylaxis for invasive mycoses in high risk patients
Ullmann, A. J., & Cornely, O. A. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280108e45 · Cited by 45
SAFDAR, A. Y. E. S. H. A. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705439 · Cited by 43
Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis
Ganassini, A., & Cazzadori, A. (1995) · Respiratory Medicine · doi:10.1016/0954-6111(95)90198-1 · Cited by 42
Seaton, A., Seaton, R. A., & Wightman, A. J. A. (1994) · QJM · doi:10.1093/oxfordjournals.qjmed.a068964 · Cited by 38
Soubani, A. O., & Qureshi, M. A. (2002) · PubMed · Cited by 36
Self-citationPrevention of group B streptococcal neonatal disease. A plea for a European consensus
Fraile, M. D. L. R., Cabero, L., Andreu, A., & Rao, G. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00196.x · Cited by 33
Wang, J. L. F., Patterson, R., Roberts, M., & Rosenberg, M. (1978) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(78)90327-5 · Cited by 33
Invasive Aspergillosis in Italian AIDS Patients
Libanore, M., Prini, E., Mazzetti, M., et al. (2002) · Infection · doi:10.1007/s15010-002-2033-1 · Cited by 31
Tsubura, E. (1997) · PubMed · Cited by 30
Israel, R. H., Poe, R. H., Bomba, P. A., & Gross, R. A. (1980) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198007000-00007 · Cited by 28
Habicht, J. M., Reichenberger, F., Gratwohl, A. A., Zerkowski, H., & Tamm, M. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00513-5 · Cited by 28
Cavitary pulmonary cryptococcosis complicated by aspergilloma.
Rosenheim, S., & Schwarz, J. (1975) · PubMed · doi:10.1164/arrd.1975.111.4.549 · Cited by 28
Pauw, B. E. D., & Patterson, T. F. (2005) · Clinical Infectious Diseases · doi:10.1086/430919 · Cited by 27
Allergic bronchopulmonary aspergillosis: an Indian perspective
Shah, A. K. (2006) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328011a284 · Cited by 26
Garnacho‐Montero, J., & Amaya‐Villar, R. (2006) · Critical Care · doi:10.1186/cc4860 · Cited by 26
Noninvasive Aspergillus Pulmonary Disease
Judson, M. A. (2004) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2004-824904 · Cited by 26
Bronchopulmonary aspergillosis--treatment with beclomethasone dipropionate.
Am, H., & Ss, C. (1975) · PubMed · Cited by 24
Polymerase chain reaction in the diagnosis of invasive aspergillosis
Hızel, K., Köktürk, N., Kalkancı, A., Ozturk, C., Kuştımur, S., & Tufan, M. A. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00944.x · Cited by 22
Mattiuzzi, G. N., Kantarjian, H. M., O'Brien, S. M., Kontoyiannis, D. P., Giles, F. J., Zhou, X., Lim, J. T., Bekele, B. N., Faderl, S. H., Cortes, J. E., et al. (2004) · Cancer · doi:10.1002/cncr.11930 · Cited by 21
Anidulafungin: A new echinocandin for the treatment of fungal infections
Cohen‐Wolkowiez, M., Benjamin, D. K., Steinbach, W. J., et al. (2006) · Drugs of today · doi:10.1358/dot.2006.42.8.996569 · Cited by 21
Aspergillose broncho-pulmonaire allergique traitée par voriconazole
Mulliez, P., Croxo, C., Georges, F., & Darras, A. (2006) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(06)71469-3 · Cited by 16
Prolonged Therapeutic Response to Voriconazole in a Case of Allergic Bronchopulmonary Aspergillosis
Gimeno, R. B., & Martínez, M. J. M. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60021-4 · Cited by 15
Shah, A. (2010) · European Respiratory Review · doi:10.1183/09059180.00009010 · Cited by 15
Danpornprasert, P., Foongladda, S., & Tscheikuna, J. (2010) · PubMed · Cited by 14
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Montani, D., Zendah, I., Achouh, L., et al. (2010) · European Respiratory Review · doi:10.1183/09059180.00004810 · Cited by 14
Respuesta terapéutica prolongada a voriconazol en un caso de broncoaspergilosis alérgica
Gimeno, R. B., & Martínez, M. J. M. (2007) · Archivos de Bronconeumología · doi:10.1157/13097002 · Cited by 11
(2003) · Cerebrovascular Diseases · doi:10.1159/000070766 · Cited by 6
Cited by
Fungal evolution: major ecological adaptations and evolutionary transitions
Naranjo‐Ortiz, M. A., & Gabaldón, T. (2019) · Biological Reviews · doi:10.1111/brv.12510 · Cited by 390
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 315
D'Haese, J., Theunissen, K., Vermeulen, E., Schoemans, H., De Vlieger, G., Lammertijn, L., Meersseman, P., Meersseman, W., Lagrou, K., & Maertens, J. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06423-11 · Cited by 186
“At particular risk are those with advanced liver cirrhosis, those who suffer from chronic obstructive pulmonary disease (COPD) for which they receive corticosteroids, and patients receiving immunomodulating drugs for the treatment of autoimmune disorders (16).”
BackgroundInteractions of Aspergillus fumigatus Conidia with Airway Epithelial Cells: A Critical Review
Croft, C. A., Culibrk, L., Moore, M. M., & Tebbutt, S. J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00472 · Cited by 142
“Patients with chronic granulomatous disease (CGD) and advanced AIDS also have an elevated risk of developing IA, as do patients receiving high-dose corticosteroid treatment (Kousha et al., 2011).”
Background
Metadata
- Authors
- Kousha, M., Tadi, R., & Soubani, A. O.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2011-08-31
- Volume
- 20
- Issue
- 121
- Pages
- 156-174
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2102731598
- Cited by
- 752
- References
- 233
- FWCI
- 18.42
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.